TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ALEC

Alector Inc

Healthcare · Biotechnology

1.90$ +3.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ALEC
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+336.3% +30.6% +36.8% +15.7% +66.9% -3.3% -21.1% -24.7% -37.4%
+355.1% +25.8% +21.9% +17.9% +77.9% -3.1% -22.1% -24.9% -37.3%
-36.2% +101.8% +36.9% -44.3% +558.7% -53.1% -51.7% -55.7% +99.3%
-36.2% +794.9% +21.6% +17.1% +77.9% -3.0% -23.0% -24.7% -38.1%
+91,752.3% -100.0% -65.0%
+11.8% +285.9% +469.9% -51.6% -9.4% +95.1%
+264.6% +40.8% -44.0% -2.8% +132.8% +11.5% -14.9% -30.0% -23.1%
+1,714.8% -52.4% +375.1% +9.9% +105.0% -32.8% +89.7% -29.7% -44.4%
-81.2% +14.4% +3.8% +3.4% +5.0% +3.5% +7.6%
-1.0% -88.9% +120.6% +980.6% +58.1% -11.8% -9.9% -41.3% -23.7%
-0.7%
+37.4% +12.4% -28.7% -37.4% -5.5% -75.8%
+502.8% +33.5% -9.7% +26.0% +3.4% +2.6% +1.5% +15.4% +6.6%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?